🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Recruitingn/aAges 15 Years - 25 YearsFemaleUniversity Hospital Erlangen
NCT06642831 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female subjects age 15-25 years * Signed written informed consent Exclusion Criteria: * Less than 1 years from onset of menarche * Use of hormonal contraceptives * Documented ongoing pregnancy * Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses \> 2 cm as detected by transvaginal ultrasound * Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany
Erlangen, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy